• 中文核心期刊要目总览
  • 中国科技核心期刊
  • 中国科学引文数据库(CSCD)
  • 中国科技论文与引文数据库(CSTPCD)
  • 中国学术期刊文摘数据库(CSAD)
  • 中国学术期刊(网络版)(CNKI)
  • 中文科技期刊数据库
  • 万方数据知识服务平台
  • 中国超星期刊域出版平台
  • 国家科技学术期刊开放平台
  • 荷兰文摘与引文数据库(SCOPUS)
  • 日本科学技术振兴机构数据库(JST)

Battle of the wall for aromatic “orifice-opening” agents: defending and breaching the blood-brain barrier

  • Abstract: Brain is the most stringently safeguarded organ in the human body. The 7 mm-thick skull protects the central nervous system (CNS) against external damage, while the blood-brain barrier (BBB) functions as a specific physiological barrier, successfully safeguarding it from circulating toxins and pathogens. BBB disruption is closely linked to the emergence and development of various CNS disorders, and the strong constraints of BBB on substance exchange present a considerable obstacle to medicine administration for the treatment of neurological diseases. Aromatic orifice-opening agents (AOOAs), a specific class of traditional Chinese medicine (TCM), exhibit a unique bidirectional interaction with BBB. Such agents can loosen the BBB junctions, transiently enhance its permeability, and ease the passage of medications into the brain, a phenomenon referred to as the “permeability-promoting” effect on BBB. In pathological settings, AOOAs can preserve BBB integrity and exert a “permeability-inhibiting” effect by reducing inflammatory responses and alleviating oxidative stress. This review systematically analyzes the regulatory factors affecting BBB permeability, investigates the mechanisms by which AOOAs protect and penetrate the BBB, and highlights the innovative opportunities and significant potential these agents present for treating CNS disorders.

     

/

返回文章
返回